Leukemia

Oncology·MeSH: Leukemia

Prevalence

6.0 / 100K

Incidence

4.3 / 100K/yr

630 drugs in development·136 companies·25 clinical trials

Drug Pipeline by Phase

Approved(40)

Drug	Company
aucatzyl	Autolus Therapeutics plc (AUTL)
azacitidine	Amneal Pharmaceuticals, Inc. (AMRX)
belrapzo	EAGLE PHARMACEUTICALS, INC. (EGRX)
bosutinib	SUNSET ISLAND GROUP (SUN)
bosutinib	Impax Laboratories, LLC (IPXL)
busulfan	Amneal Pharmaceuticals, Inc. (AMRX)
busulfan	NEXUS BIOPHARMA INC (NEXS)
clofarabine	Mersana Therapeutics, Inc. (MRSN)
clofarabine	DR REDDYS LABORATORIES LTD (RDY)
clonoSEQ	Adaptive Biotechnologies Corp (ADPT)
company's product candidate uproleselan	CRESCENT BIOPHARMA, INC. (CBIO)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
daurismo	PFIZER INC (PFE)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
hydroxyurea	AVEDRO INC (AVDR)
imatinib	Mylan II B.V. (MYL)
imatinib	Amneal Pharmaceuticals, Inc. (AMRX)
imatinib	Aptinyx Inc. (APTX)
imatinib	Teva Pharmaceutical Industries Limited (TEVA)
imatinib	DR REDDYS LABORATORIES LTD (RDY)
imatinib	SUNSET ISLAND GROUP (SUN)
imkeldi	CG Oncology, Inc. (CGON)
Jaypirca	ELI LILLY & Co (LLY)
Jaypirca®	ELI LILLY & Co (LLY)
komzifti	Kura Oncology, Inc. (KURA)
kymriah	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
nelarabine	Amneal Pharmaceuticals, Inc. (AMRX)
nelarabine	NEXUS BIOPHARMA INC (NEXS)
nilotinib	Mersana Therapeutics, Inc. (MRSN)
nilotinib	Aptinyx Inc. (APTX)
nilotinib	DR REDDYS LABORATORIES LTD (RDY)
nypozi	GT Biopharma, Inc. (GTBP)
Revuforj	Syndax Pharmaceuticals Inc (SNDX)
rezlidhia	RIGEL PHARMACEUTICALS INC (RIGL)
Rylaze / Enrylaze	Jazz Pharmaceuticals plc (JAZZ)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
venetoclax	DR REDDYS LABORATORIES LTD (RDY)
viibryd	AbbVie Inc. (ABBV)
zydelig	GILEAD SCIENCES, INC. (GILD)

Phase 3(209)

Drug	Company
6-Mercaptopurine	Filana Therapeutics Inc. (FLNA)
abl001 200mg qd	Novartis AG (NVS)
abl001 200mg qd	NOVARTIS AG (NVSEF)
abl001 40mg bid	NOVARTIS AG (NVSEF)
abl001 40mg bid	Novartis AG (NVS)
abl001 80mg qd	Novartis AG (NVS)
abl001 80mg qd	NOVARTIS AG (NVSEF)
Acalabrutinib	Merck & Co., Inc. (MRK)
Acalabrutinib	AbbVie Inc. (ABBV)
Acalabrutinib	Merus N.V. (MRUS)
alxn2075	ALEXION PHARMACEUTICALS, INC. (ALXN)
ara-c±ida	SUNSHINE BIOPHARMA INC. (SBFM)
asciminib	GH Research PLC (GHRS)
asciminib	Novartis AG (NVS)
asciminib single agent	NOVARTIS AG (NVSEF)
Asparaginase Erwinia chrysanthemi	Cosmos Health Inc. (COSM)
Asparaginase Erwinia chrysanthemi	Assertio Holdings, Inc. (ASRT)
azacitadine	GH Research PLC (GHRS)
AZD0486	ASTRAZENECA PLC (AZN)
bendamustine	LOXO ONCOLOGY, INC. (LOXO)
bendamustine	BeOne Medicines Ltd. (ONC)
bendamustine	BeOne Medicines Ltd. (ONC)
Bendamustine	ENANTA PHARMACEUTICALS INC (ENTA)
Bendamustine	BeOne Medicines Ltd. (ONC)
BGB-11417	BeOne Medicines Ltd. (ONC)
bgb-16673	BeOne Medicines Ltd. (ONC)
BGB-16673	BeOne Medicines Ltd. (ONC)
BGB-16673	ENANTA PHARMACEUTICALS INC (ENTA)
BGB-16673	Merus N.V. (MRUS)
Bleomycin Sulfate	Filana Therapeutics Inc. (FLNA)
Bleomycin Sulfate	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Blinatumomab	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Blinatumomab	Cosmos Health Inc. (COSM)
Blinatumomab	Crinetics Pharmaceuticals, Inc. (CRNX)
Blinatumomab	Assertio Holdings, Inc. (ASRT)
bosutinib	GH Research PLC (GHRS)
bosutinib	Novartis AG (NVS)
bosutinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Calaspargase	Filana Therapeutics Inc. (FLNA)
Calaspargase Pegol	Merus N.V. (MRUS)
Calaspargase Pegol	Assertio Holdings, Inc. (ASRT)
Calaspargase Pegol	Filana Therapeutics Inc. (FLNA)
Calaspargase Pegol	Cosmos Health Inc. (COSM)
Calaspargase Pegol	AXIM BIOTECHNOLOGIES, INC. (AXIM)
CAR-T	Filana Therapeutics Inc. (FLNA)
CD22 CAR-transduced T cells	Filana Therapeutics Inc. (FLNA)
cellcept	Filana Therapeutics Inc. (FLNA)
cellcept	ENANTA PHARMACEUTICALS INC (ENTA)
cellcept	Structure Therapeutics Inc. (GPCR)
ceplene	IMMUNE PHARMACEUTICALS INC (IMNP)
chemotherapy agents	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Cladribine	Jazz Pharmaceuticals plc (JAZZ)
clifutinib	SUNSHINE BIOPHARMA INC. (SBFM)
Clofarabine	Merus N.V. (MRUS)
CPX-351	Jazz Pharmaceuticals plc (JAZZ)
ctl019	Novartis AG (NVS)
CTL019	Novartis AG (NVS)
Cytarabine	Crinetics Pharmaceuticals, Inc. (CRNX)
Cytarabine	Assertio Holdings, Inc. (ASRT)
Cytarabine	Merus N.V. (MRUS)
Cytarabine	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Cytarabine	Cosmos Health Inc. (COSM)
Cytarabine	Jazz Pharmaceuticals plc (JAZZ)
Cytarabine + Daunorubicin + Gilteritinib	Merus N.V. (MRUS)
Cytarabine + Daunorubicin + Gilteritinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Dasatinib	Assertio Holdings, Inc. (ASRT)
Dasatinib	Filana Therapeutics Inc. (FLNA)
Dasatinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Dasatinib	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Dasatinib	Cosmos Health Inc. (COSM)
Daunorubicin	AbbVie Inc. (ABBV)
Daunorubicin	Cosmos Health Inc. (COSM)
Daunorubicin	Jazz Pharmaceuticals plc (JAZZ)
Daunorubicin	Assertio Holdings, Inc. (ASRT)
Daunorubicin Hydrochloride	Merus N.V. (MRUS)
Daunorubicin Hydrochloride	Assertio Holdings, Inc. (ASRT)
Daunorubicin Hydrochloride	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Daunorubicin Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Dexrazoxane Hydrochloride	Assertio Holdings, Inc. (ASRT)
Filgrastim	Assertio Holdings, Inc. (ASRT)
flag-ida	SUNSHINE BIOPHARMA INC. (SBFM)
galinpepimut-s	SELLAS Life Sciences Group, Inc. (SLS)
gamunex-c	Grifols S.A. (GRFS)
Gemtuzumab Ozogamicin	Assertio Holdings, Inc. (ASRT)
gilteritinib	GH Research PLC (GHRS)
Gilteritinib Fumarate	Assertio Holdings, Inc. (ASRT)
gm-csf	SELLAS Life Sciences Group, Inc. (SLS)
HiDAC	Merus N.V. (MRUS)
High intensity therapies	Structure Therapeutics Inc. (GPCR)
hmpl-306 regimen	HUTCHMED (China) Ltd (HMDCF)
Hydrocortisone	Merus N.V. (MRUS)
Hydrocortisone	Assertio Holdings, Inc. (ASRT)
Hydrocortisone Sodium Succinate	Assertio Holdings, Inc. (ASRT)
hypercvad	AMGEN INC (AMGN)
Ibrutinib	AbbVie Inc. (ABBV)
Ibrutinib	Merck & Co., Inc. (MRK)
idarubicin	GH Research PLC (GHRS)
Idarubicin	AbbVie Inc. (ABBV)
Idelalisib	ENANTA PHARMACEUTICALS INC (ENTA)
Idelalisib	Merus N.V. (MRUS)
Ifosfamide	Assertio Holdings, Inc. (ASRT)
imatinib	GH Research PLC (GHRS)
Imatinib	Cosmos Health Inc. (COSM)
Imatinib Mesylate	Assertio Holdings, Inc. (ASRT)
Imatinib Mesylate	Filana Therapeutics Inc. (FLNA)
induction phase	GH Research PLC (GHRS)
inotuzumab	GH Research PLC (GHRS)
Inotuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
Inotuzumab ozogamicin	Assertio Holdings, Inc. (ASRT)
Inotuzumab Ozogamicin	Filana Therapeutics Inc. (FLNA)
Inotuzumab Ozogamicin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Intensive Chemotherapy Regimen	Syndax Pharmaceuticals Inc (SNDX)
intrathecal chemotherapy	GH Research PLC (GHRS)
Isatuximab	Sanofi (SNY)
JCAR017 + venetoclax	Merus N.V. (MRUS)
kite-439	Kite Pharma, Inc. (KITE)
kite-585	Kite Pharma, Inc. (KITE)
kite-718	Kite Pharma, Inc. (KITE)
kite-796	Kite Pharma, Inc. (KITE)
kte-c19	Kite Pharma, Inc. (KITE)
leucovorin	GH Research PLC (GHRS)
Leucovorin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Leucovorin	Cosmos Health Inc. (COSM)
Leucovorin Calcium	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Leucovorin Calcium	Cosmos Health Inc. (COSM)
Levoleucovorin	Cosmos Health Inc. (COSM)
Levoleucovorin	Assertio Holdings, Inc. (ASRT)
Liposome-encapsulated Daunorubicin-Cytarabine	Assertio Holdings, Inc. (ASRT)
Liposome-encapsulated Daunorubicin-Cytarabine	Merus N.V. (MRUS)
Liposome-encapsulated Daunorubicin-Cytarabine	Jazz Pharmaceuticals plc (JAZZ)
liso-cel	CELGENE CORP /DE/ (CELG)
lodac	SUNSHINE BIOPHARMA INC. (SBFM)
Low intensity therapies	Crinetics Pharmaceuticals, Inc. (CRNX)
Low intensity therapies	Structure Therapeutics Inc. (GPCR)
low-intensity chemotherapy regimen	AMGEN INC (AMGN)
maintenance	GH Research PLC (GHRS)
Mercaptopurine	Filana Therapeutics Inc. (FLNA)
Mercaptopurine	Assertio Holdings, Inc. (ASRT)
Mercaptopurine	ENANTA PHARMACEUTICALS INC (ENTA)
Mercaptopurine	Cosmos Health Inc. (COSM)
Mercaptopurine Oral Suspension	Cosmos Health Inc. (COSM)
Mercaptopurine Oral Suspension	Assertio Holdings, Inc. (ASRT)
Mesna	Crinetics Pharmaceuticals, Inc. (CRNX)
Mesna	Merus N.V. (MRUS)
Mesna	Assertio Holdings, Inc. (ASRT)
Mesna	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Mitoxantrone Hydrochloride	Assertio Holdings, Inc. (ASRT)
Momelotinib	Merus N.V. (MRUS)
Nemtabrutinib	Merus N.V. (MRUS)
nilotinib	GH Research PLC (GHRS)
obinutuzumab	BeOne Medicines Ltd. (ONC)
Obinutuzumab	AbbVie Inc. (ABBV)
Obinutuzumab	ASTRAZENECA PLC (AZN)
Ofatumumab	ENANTA PHARMACEUTICALS INC (ENTA)
parsaclisib	Incyte Corp. (INCY)
Pegaspargase	ENANTA PHARMACEUTICALS INC (ENTA)
Pegaspargase	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Pegaspargase	Cosmos Health Inc. (COSM)
Pegaspargase	Merus N.V. (MRUS)
pevonedistat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
pevonedistat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Pirtobrutinib	BeOne Medicines Ltd. (ONC)
ponatinib	Incyte Corp. (INCY)
Ponatinib	ENANTA PHARMACEUTICALS INC (ENTA)
ponatinib 30mg od	GH Research PLC (GHRS)
ponatinib 45mg od	GH Research PLC (GHRS)
Ponatinib Hydrochloride	Assertio Holdings, Inc. (ASRT)
Ponatinib Hydrochloride	Crinetics Pharmaceuticals, Inc. (CRNX)
Ponatinib Hydrochloride	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Procarbazine Hydrochloride	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Revumenib	UNITED THERAPEUTICS Corp (UTHR)
Roginolisib	ENANTA PHARMACEUTICALS INC (ENTA)
salvage chemotherapy regimen	HUTCHMED (China) Limited (HCM)
salvage chemotherapy regimen	HUTCHMED (China) Ltd (HMDCF)
Selumetinib Sulfate	Merus N.V. (MRUS)
sonrotoclax	BeOne Medicines Ltd. (ONC)
Sonrotoclax	BeOne Medicines Ltd. (ONC)
Sonrotoclax	ENANTA PHARMACEUTICALS INC (ENTA)
Sonrotoclax	Filana Therapeutics Inc. (FLNA)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Tacrolimus	Structure Therapeutics Inc. (GPCR)
tafasitamab	Incyte Corp. (INCY)
Therapeutic Hydrocortisone	Assertio Holdings, Inc. (ASRT)
Thioguanine	Assertio Holdings, Inc. (ASRT)
Thioguanine	Merus N.V. (MRUS)
Thioguanine	ENANTA PHARMACEUTICALS INC (ENTA)
Thioguanine	Cosmos Health Inc. (COSM)
Ublituximab	ASTRAZENECA PLC (AZN)
Venetoclax	Merus N.V. (MRUS)
Venetoclax	Crinetics Pharmaceuticals, Inc. (CRNX)
Venetoclax	ASTRAZENECA PLC (AZN)
Venetoclax	Merck & Co., Inc. (MRK)
Venetoclax	BeOne Medicines Ltd. (ONC)
Venetoclax	ENANTA PHARMACEUTICALS INC (ENTA)
Venetoclax	UNITED THERAPEUTICS Corp (UTHR)
Venetoclax 400	UNITED THERAPEUTICS Corp (UTHR)
Vinblastine Sulfate	AXIM BIOTECHNOLOGIES, INC. (AXIM)
vincristine	Incyte Corp. (INCY)
vincristine	GH Research PLC (GHRS)
Vincristine	Assertio Holdings, Inc. (ASRT)
Vincristine	Cosmos Health Inc. (COSM)
Vincristine	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Vincristine Sulfate	Cosmos Health Inc. (COSM)
Vincristine Sulfate	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Vincristine Sulfate	Assertio Holdings, Inc. (ASRT)
Vincristine Sulfate	Crinetics Pharmaceuticals, Inc. (CRNX)
Vyxeos	Jazz Pharmaceuticals plc (JAZZ)
Zanubrutinib	Filana Therapeutics Inc. (FLNA)
zilovertamab	Oncternal Therapeutics, Inc. (ONCT)

Phase 2(176)

Drug	Company
6-Mercaptopurine	Assertio Holdings, Inc. (ASRT)
ABBV-787	AbbVie Inc. (ABBV)
abl001/asciminib	Novartis AG (NVS)
Acetaminophen	Merus N.V. (MRUS)
Acetaminophen	Assertio Holdings, Inc. (ASRT)
Acetaminophen	ENANTA PHARMACEUTICALS INC (ENTA)
acr-6840	Acrivon Therapeutics, Inc. (ACRV)
ALLO-501A	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
ALT-803	ImmunityBio, Inc. (IBRX)
apg-115	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Asciminib	Novartis AG (NVS)
asparaginase erwinia chrysanthemi	Incyte Corp. (INCY)
Asparaginase Erwinia chrysanthemi	AXIM BIOTECHNOLOGIES, INC. (AXIM)
atg	GH Research PLC (GHRS)
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
bcr-abl tyrosine kinase inhibitor	GH Research PLC (GHRS)
Blinatumomab	Merus N.V. (MRUS)
Bortezomib	Structure Therapeutics Inc. (GPCR)
BP1001	BIO-PATH HOLDINGS, INC. (BPTH)
Busulfan	Merus N.V. (MRUS)
Busulfan	Valneva SE (VALN)
Calaspargase	Assertio Holdings, Inc. (ASRT)
Camonsertib (RP-3500)	Repare Therapeutics Inc. (RPTX)
CAR T-cells	ENANTA PHARMACEUTICALS INC (ENTA)
cc-486	BRISTOL MYERS SQUIBB CO (BMY)
cd19+	GH Research PLC (GHRS)
cd45ra-depleted dli	GH Research PLC (GHRS)
Cetuximab Sarotalocan Sodium	Merus N.V. (MRUS)
CLLS52	Cellectis S.A. (CLLS)
Clofarabine	ENANTA PHARMACEUTICALS INC (ENTA)
Clofarabine	Structure Therapeutics Inc. (GPCR)
cnct19	CASI Pharmaceuticals, Inc (DE) (CASI)
conditioning regimen a	HWH International Inc. (HWH)
conditioning regimen b	HWH International Inc. (HWH)
conditioning regimen c	HWH International Inc. (HWH)
conditioning regimen d	HWH International Inc. (HWH)
conditioning regimen e	HWH International Inc. (HWH)
cytarabine	Incyte Corp. (INCY)
Cytarabine	ENANTA PHARMACEUTICALS INC (ENTA)
Cytarabine	AbbVie Inc. (ABBV)
Cytarabine	Cidara Therapeutics, Inc. (CDTX)
Cytarabine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Cytarabine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Dasatinib	Merus N.V. (MRUS)
daunorubicin	Merus N.V. (MRUS)
Daunorubicin	ENANTA PHARMACEUTICALS INC (ENTA)
daunorubicin or idarubicin	NOVARTIS AG (NVSEF)
daunorubicin or idarubicin	Novartis AG (NVS)
Daunorubicin or Idarubicin	Merus N.V. (MRUS)
Diphenhydramine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Diphenhydramine	Assertio Holdings, Inc. (ASRT)
Diphenhydramine	Merus N.V. (MRUS)
Diphenhydramine	Cidara Therapeutics, Inc. (CDTX)
Diphenhydramine	ENANTA PHARMACEUTICALS INC (ENTA)
dzd8586	NYMOX PHARMACEUTICAL CORP (NYMXF)
emavusertib	CURIS INC (CRIS)
Emavusertib (CA-4948)	CURIS INC (CRIS)
Enasidenib	Merus N.V. (MRUS)
Etoposide	Structure Therapeutics Inc. (GPCR)
Filgrastim	Merus N.V. (MRUS)
Filgrastim	Filana Therapeutics Inc. (FLNA)
filgrastim or equivalent	Sanofi (SNY)
Flotetuzumab	MACROGENICS INC (MGNX)
fludarabine	Novartis AG (NVS)
fludarabine	HWH International Inc. (HWH)
fludarabine	NOVARTIS AG (NVSEF)
fludarabine	Sanofi (SNY)
Fludarabine	Merus N.V. (MRUS)
Fludarabine	Valneva SE (VALN)
Fludarabine Phosphate	Merus N.V. (MRUS)
g-csf	GH Research PLC (GHRS)
G-CSF	ImmunityBio, Inc. (IBRX)
gemtuzumab ozogamicin	GH Research PLC (GHRS)
Gemtuzumab Ozogamicin	Merus N.V. (MRUS)
Gemtuzumab Ozogamicin	ENANTA PHARMACEUTICALS INC (ENTA)
Gilteritinib	Merus N.V. (MRUS)
Glasdegib	Jazz Pharmaceuticals plc (JAZZ)
Hydrocortisone	Structure Therapeutics Inc. (GPCR)
Hydrocortisone	Cidara Therapeutics, Inc. (CDTX)
Hydrocortisone	ENANTA PHARMACEUTICALS INC (ENTA)
Hydrocortisone	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hydrocortisone	PROTHENA CORP PUBLIC LTD CO (PRTA)
idarubicin	Sanofi (SNY)
Ifosfamide	Merus N.V. (MRUS)
Inotuzumab	Assertio Holdings, Inc. (ASRT)
Inotuzumab ozogamicin	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Inotuzumab ozogamicin	PROTHENA CORP PUBLIC LTD CO (PRTA)
Inotuzumab ozogamicin	Merus N.V. (MRUS)
Inotuzumab ozogamicin	Structure Therapeutics Inc. (GPCR)
Inotuzumab ozogamicin	ENANTA PHARMACEUTICALS INC (ENTA)
Inotuzumab ozogamicin	Cidara Therapeutics, Inc. (CDTX)
isatuximab	Sanofi (SNY)
l - asparaginase	Sanofi (SNY)
l - asparginase	Sanofi (SNY)
leucovorin	Incyte Corp. (INCY)
Levoleucovorin	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Levoleucovorin	Filana Therapeutics Inc. (FLNA)
liposomal daunorubicin	Sanofi (SNY)
Lymphodepletion Conditioning	Filana Therapeutics Inc. (FLNA)
mb-cart19.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Melphalan	Valneva SE (VALN)
Melphalan	Merus N.V. (MRUS)
mercaptopurine	Merus N.V. (MRUS)
mercaptopurine	Incyte Corp. (INCY)
mitoxantrone	NOVARTIS AG (NVSEF)
mitoxantrone	Sanofi (SNY)
mitoxantrone	Novartis AG (NVS)
mitoxantrone	Filana Therapeutics Inc. (FLNA)
mitoxantrone	Merus N.V. (MRUS)
mitoxantrone	GH Research PLC (GHRS)
Mitoxantrone	Jazz Pharmaceuticals plc (JAZZ)
mt-401	Marker Therapeutics, Inc. (MRKR)
mt-401-ots	Marker Therapeutics, Inc. (MRKR)
Mycophenolate mofetil	ImmunityBio, Inc. (IBRX)
nexi-001	NexImmune, Inc. (NEXI)
Obe-cel (AUTO1)	Autolus Therapeutics plc (AUTL)
Ofatumumab	Structure Therapeutics Inc. (GPCR)
Ofatumumab	Merus N.V. (MRUS)
Ofatumumab	Filana Therapeutics Inc. (FLNA)
Olutasidenib	Merus N.V. (MRUS)
out-of-specification obecabtagene autoleucel	Autolus Therapeutics plc (AUTL)
oxi4503	Oncotelic Therapeutics, Inc. (OTLC)
pegaspargase	Incyte Corp. (INCY)
pegaspargase asparaginase	Sanofi (SNY)
Pegfilgrastim	Filana Therapeutics Inc. (FLNA)
Pegfilgrastim	Merus N.V. (MRUS)
Pegfilgrastim	Assertio Holdings, Inc. (ASRT)
Pirtobrutinib	Filana Therapeutics Inc. (FLNA)
Pirtobrutinib	AbbVie Inc. (ABBV)
Pirtobrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
pivekimab sunirine	ImmunoGen, Inc. (IMGN)
Ponatinib	Assertio Holdings, Inc. (ASRT)
Ponatinib	Filana Therapeutics Inc. (FLNA)
post-remission	GH Research PLC (GHRS)
post-transplant abatacept	HWH International Inc. (HWH)
post-transplant abatacept	GH Research PLC (GHRS)
post-transplant mycophenolate mofetil	HWH International Inc. (HWH)
post-transplant tacrolimus	HWH International Inc. (HWH)
post-transplant tacrolimus	GH Research PLC (GHRS)
ptcy (25 mg/kg d3	HWH International Inc. (HWH)
ptcy (25 mg/kg d3	GH Research PLC (GHRS)
ptcy (50 mg/kg d3	GH Research PLC (GHRS)
ptcy (50 mg/kg d3	HWH International Inc. (HWH)
re-induction phase	GH Research PLC (GHRS)
Recombinant Granulocyte Colony-Stimulating Factor	Jazz Pharmaceuticals plc (JAZZ)
revumenib	GH Research PLC (GHRS)
RP-3500	Repare Therapeutics Inc. (RPTX)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
Sodium Thiosulfate	Merus N.V. (MRUS)
supportive care	HWH International Inc. (HWH)
Tacrolimus	ImmunityBio, Inc. (IBRX)
tagraxofusp	STEMLINE THERAPEUTICS INC (STML)
tamibarotene	Syros Pharmaceuticals, Inc. (SYRS)
tcb008	TC BioPharm (Holdings) plc (TCBWF)
tcrα/β+	GH Research PLC (GHRS)
tecartus	GH Research PLC (GHRS)
tern-701	Terns Pharmaceuticals, Inc. (TERN)
Therapeutic Hydrocortisone	Cosmos Health Inc. (COSM)
Therapeutic Hydrocortisone	AXIM BIOTECHNOLOGIES, INC. (AXIM)
thioguanine	Incyte Corp. (INCY)
UCART123v1.2	Cellectis S.A. (CLLS)
UCART22	Cellectis S.A. (CLLS)
umbralisib	GH Research PLC (GHRS)
Venetoclax	Valneva SE (VALN)
Venetoclax	Assertio Holdings, Inc. (ASRT)
Venetoclax	Cosmos Health Inc. (COSM)
Venetoclax	AXIM BIOTECHNOLOGIES, INC. (AXIM)
Venetoclax	FATE THERAPEUTICS INC (FATE)
Vinblastine Sulfate	Merus N.V. (MRUS)
vincristine	Merus N.V. (MRUS)
vincristine	Sanofi (SNY)
Vincristine Sulfate	Merus N.V. (MRUS)
Vincristine Sulfate Liposome	Merus N.V. (MRUS)
Vincristine Sulfate Liposome	Structure Therapeutics Inc. (GPCR)
Zanubrutinib	CURIS INC (CRIS)

Phase 1(112)

Drug	Company
ABT-199	AbbVie Inc. (ABBV)
ABT-263	AbbVie Inc. (ABBV)
ACLX-002	Arcellx, Inc. (ACLX)
ADCLEC.syn1 CAR T cells	Filana Therapeutics Inc. (FLNA)
ADCLEC.syn1 CAR T cells	Merus N.V. (MRUS)
ADCT-602	ADC Therapeutics SA (ADCT)
Alvocidib	AbbVie Inc. (ABBV)
AMG 176	AbbVie Inc. (ABBV)
anti-cd19 car-based product candidate	Kite Pharma, Inc. (KITE)
Anti-CD19-chimeric-antigen-receptor-transduced T cells	Twist Bioscience Corp (TWST)
apg-2575	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
apg2575	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
ascentage pharma hqp1351 bioavailable inhibitor	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
astx727	CG Oncology, Inc. (CGON)
ASTX727	Syndax Pharmaceuticals Inc (SNDX)
bendamustine	AbbVie Inc. (ABBV)
Bleximenib	Merus N.V. (MRUS)
blinatumomab	AMGEN INC (AMGN)
blinatumomab	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Blinatumomab	AbbVie Inc. (ABBV)
BMF-500	Biomea Fusion, Inc. (BMEA)
BP1002	BIO-PATH HOLDINGS, INC. (BPTH)
Bridging Therapy	Filana Therapeutics Inc. (FLNA)
CB-012	Caribou Biosciences, Inc. (CRBU)
cb-5339	CASI Pharmaceuticals, Inc (DE) (CASI)
cd19-car t-cells	GH Research PLC (GHRS)
CD371-specific/YSNVz/I-18 CAR T cells	Merus N.V. (MRUS)
Chemotherapy Regimen	Syndax Pharmaceuticals Inc (SNDX)
CLN-049	Cullinan Therapeutics, Inc. (CGEM)
Conditioning chemotherapy	Filana Therapeutics Inc. (FLNA)
Cytarabine	Syndax Pharmaceuticals Inc (SNDX)
Cytarabine	Structure Therapeutics Inc. (GPCR)
Cytarabine	Accustem Sciences Inc. (ACUT)
Dasatinib	AbbVie Inc. (ABBV)
Donor-derived Mesenchymal Stromal Cells	ENANTA PHARMACEUTICALS INC (ENTA)
duvelisib	AbbVie Inc. (ABBV)
elvn-001	Enliven Therapeutics, Inc. (ELVN)
epcoritamab	Genmab A/S (GMAB)
Epcoritamab	Filana Therapeutics Inc. (FLNA)
Epcoritamab	ELI LILLY & Co (LLY)
Epcoritamab	ENANTA PHARMACEUTICALS INC (ENTA)
Etoposide Phosphate	Accustem Sciences Inc. (ACUT)
FCR	AbbVie Inc. (ABBV)
Filgrastim	AbbVie Inc. (ABBV)
Fludarabine	AbbVie Inc. (ABBV)
Fludarabine	PRECIGEN, INC. (PGEN)
Gemtuzumab Ozogamicin	Jazz Pharmaceuticals plc (JAZZ)
Gilteritinib	Jazz Pharmaceuticals plc (JAZZ)
Gilteritinib	AbbVie Inc. (ABBV)
Granulocyte Colony-Stimulating Factor	AbbVie Inc. (ABBV)
HiDAC	Syndax Pharmaceuticals Inc (SNDX)
High dose IL-2	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Iadademstat	Merus N.V. (MRUS)
Idarubicin	Structure Therapeutics Inc. (GPCR)
IL-2	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Imetelstat	Assertio Holdings, Inc. (ASRT)
inb-100	IN8BIO, INC. (INAB)
IOV-2001	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IPI-145	Filana Therapeutics Inc. (FLNA)
jcar017	Juno Therapeutics, Inc. (JUNO)
JCAR017	Merus N.V. (MRUS)
JCAR017 + ibrutinib	Merus N.V. (MRUS)
jnj-90189892	GH Research PLC (GHRS)
KT-253	Kymera Therapeutics, Inc. (KYMR)
kur-502	Athenex, Inc. (ATNX)
Low dose IL-2	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LOXO-338	ELI LILLY & Co (LLY)
Luveltamab tazevibulin	SUTRO BIOPHARMA, INC. (STRO)
mb-106	MUSTANG BIO, INC. (MBIO)
MCLA-117 bispecific antibody	Merus N.V. (MRUS)
memory-like natural killer cells	ENANTA PHARMACEUTICALS INC (ENTA)
MGD024	MACROGENICS INC (MGNX)
mipletamig	Aptevo Therapeutics Inc. (APVO)
Mitoxantrone Hydrochloride	Accustem Sciences Inc. (ACUT)
Mogamulizumab	Filana Therapeutics Inc. (FLNA)
Natural Killer Cell Therapy	Filana Therapeutics Inc. (FLNA)
Navtemadlin	Merus N.V. (MRUS)
nc525	NextCure, Inc. (NXTC)
NeoVax	BioNTech SE (BNTX)
NX-2127	Nurix Therapeutics, Inc. (NRIX)
NX-5948	Nurix Therapeutics, Inc. (NRIX)
NX-5948	Keros Therapeutics, Inc. (KROS)
Olaparib	Repare Therapeutics Inc. (RPTX)
Onvansertib (Onv)	Cardiff Oncology, Inc. (CRDF)
Pitavastatin	UNITED THERAPEUTICS Corp (UTHR)
Pivekimab Sunirine	AbbVie Inc. (ABBV)
Pivekimab Sunirine	Structure Therapeutics Inc. (GPCR)
Posaconazole	AbbVie Inc. (ABBV)
PRGN-3007	PRECIGEN, INC. (PGEN)
quizartinib	Kura Oncology, Inc. (KURA)
Revumenib	Merus N.V. (MRUS)
Revumenib	Syndax Pharmaceuticals Inc (SNDX)
Revumenib	AbbVie Inc. (ABBV)
Roginolisib	UNITED THERAPEUTICS Corp (UTHR)
sgr-2921	Schrodinger, Inc. (SDGR)
siremadlin	Novartis AG (NVS)
sl-172154	Shattuck Labs, Inc. (STTK)
SNDX-5613	Merus N.V. (MRUS)
SNDX-5613	Syndax Pharmaceuticals Inc (SNDX)
sy-2101	Syros Pharmaceuticals, Inc. (SYRS)
Tazemetostat	Merus N.V. (MRUS)
Venetoclax	Actinium Pharmaceuticals, Inc. (ATNM)
Venetoclax	Syndax Pharmaceuticals Inc (SNDX)
Vincristine	Structure Therapeutics Inc. (GPCR)
Vorinostat	Merus N.V. (MRUS)
voruciclib	Lite Strategy, Inc. (LITS)
vyxeos	GH Research PLC (GHRS)
Vyxeos liposomal	Jazz Pharmaceuticals plc (JAZZ)
YK012	Merus N.V. (MRUS)
ze 50-0134	Rani Therapeutics Holdings, Inc. (RANI)
ze50-0134	Rani Therapeutics Holdings, Inc. (RANI)
ZN-d5	Zentalis Pharmaceuticals, Inc. (ZNTL)

Preclinical(21)

Drug	Company
ACLX-004	Arcellx, Inc. (ACLX)
al101	OLD AYALA, INC (AYLA)
BCR-ABL TKI	Theseus Pharmaceuticals, Inc. (THRX)
cd38-gear-nk	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-GEAR-NK	Coeptis Therapeutics Holdings Inc. (COEP)
gb3226	Damora Therapeutics, Inc. (DMRA)
gtb-3550	GT Biopharma, Inc. (GTBP)
hicar-t	Orgenesis Inc. (ORGS)
inb-600	IN8BIO, INC. (INAB)
km10544	Emmaus Life Sciences, Inc. (EMMA)
lenzilumab	HUMANIGEN, INC (HGEN)
mt-0169	Molecular Templates, Inc. (MTEM)
oncotox-aml	OMEROS CORP (OMER)
pf743	Pfenex Inc. (PFNX)
pf745	Pfenex Inc. (PFNX)
prime edited scip	Prime Medicine, Inc. (PRME)
rasp-101	ACTAVIA LIFE SCIENCES, INC. (RASP)
rasp-201	ACTAVIA LIFE SCIENCES, INC. (RASP)
rasp-301	ACTAVIA LIFE SCIENCES, INC. (RASP)
tp-2846	LA JOLLA PHARMACEUTICAL CO (LJPC)
tp-2846	TETRAPHASE PHARMACEUTICALS INC (TTPH)

Unknown(2)

Drug	Company
BST-236	Ayala Pharmaceuticals, Inc. (ADXS)
puzolcabtagene autoleucel	PRECISION BIOSCIENCES INC (DTIL)

Clinical(1)

Drug	Company
ast-vac1	ASTERIAS BIOTHERAPEUTICS, INC. (AST)

N/A(1)

Drug	Company
LILRB4 STAR-T cells injection	Filana Therapeutics Inc. (FLNA)

Phase 1/Phase 2(24)

Drug	Company
apg-2575	CHINA PHARMA HOLDINGS, INC. (CPHI)
asciminib adult formulation	Novartis AG (NVS)
asciminib adult formulation group	Novartis AG (NVS)
asciminib pediatric formulation	Novartis AG (NVS)
asciminib pediatric formulation group	Novartis AG (NVS)
auto1	Autolus Therapeutics plc (AUTL)
AUTO1/22	Autolus Therapeutics plc (AUTL)
BGB-10188	BeOne Medicines Ltd. (ONC)
blinatumomab	Novartis AG (NVS)
cd33cart allogeneic	HWH International Inc. (HWH)
cd33cart autologous	HWH International Inc. (HWH)
cobicistat	Syndax Pharmaceuticals Inc (SNDX)
debio 1562m	HWH International Inc. (HWH)
ft-2102	Forma Therapeutics Holdings, Inc. (FMTX)
gdx012	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
gdx012	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
mb-dnpm1-tcr.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
mp0533 (multispecific darpin cd3 engager targeting cd33	MOLECULAR PARTNERS AG (MOLN)
mp0533 with obinutuzumab pretreatment	MOLECULAR PARTNERS AG (MOLN)
nkx101	Nkarta, Inc. (NKTX)
Posaconazole	BeOne Medicines Ltd. (ONC)
rapcabtagene autoleucel single agent	Novartis AG (NVS)
sar443579	Sanofi (SNY)
vincristine	Novartis AG (NVS)

Phase 2/Phase 3(12)

Drug	Company
6-mercaptopurine	GH Research PLC (GHRS)
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
annamycin	Moleculin Biotech, Inc. (MBRX)
asparaginase erwinia chrysanthemi	GH Research PLC (GHRS)
asparaginase erwinia chrysanthemi	GH Research PLC (GHRS)
blinatumomab	GH Research PLC (GHRS)
calaspargase	GH Research PLC (GHRS)
calaspargase pegol	GH Research PLC (GHRS)
erwinase	GH Research PLC (GHRS)
liposomal annamycin	Moleculin Biotech, Inc. (MBRX)
pegaspargase	GH Research PLC (GHRS)
post-transplant mycophenolate mofetil	GH Research PLC (GHRS)

Phase 4(32)

Drug	Company
Acalabrutinib	BeOne Medicines Ltd. (ONC)
Acalabrutinib	ASTRAZENECA PLC (AZN)
asciminib single agent	Novartis AG (NVS)
asciminib single agent pediatric formulation	Novartis AG (NVS)
asciminib single agent pediatric formulation	NOVARTIS AG (NVSEF)
BCG vaccine	Cidara Therapeutics, Inc. (CDTX)
bms-986497	BRISTOL MYERS SQUIBB CO (BMY)
bosutinib	Novartis AG (NVS)
Clofarabine	Filana Therapeutics Inc. (FLNA)
cyp1a2	RIGEL PHARMACEUTICALS INC (RIGL)
Daunorubicin	Filana Therapeutics Inc. (FLNA)
Ibrutinib	ELI LILLY & Co (LLY)
Idelalisib	ELI LILLY & Co (LLY)
imatinib	Novartis AG (NVS)
imatinib	Novartis AG (NVS)
Inactivated Influenza Vaccine	Cidara Therapeutics, Inc. (CDTX)
Induction therapy	Filana Therapeutics Inc. (FLNA)
Infusion of HS-IT101 Injection	Filana Therapeutics Inc. (FLNA)
nilotinib	Novartis AG (NVS)
nilotinib	Novartis AG (NVS)
NK Cells	ENANTA PHARMACEUTICALS INC (ENTA)
Non interventional study	ASTRAZENECA PLC (AZN)
Pirtobrutinib	ELI LILLY & Co (LLY)
ponatinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
ponatinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Quadrivalent Subunit Influenza Vaccine	Cidara Therapeutics, Inc. (CDTX)
Seasonal influenza vaccine	Cidara Therapeutics, Inc. (CDTX)
Subunit Influenza Vaccine	Cidara Therapeutics, Inc. (CDTX)
Venetoclax	AbbVie Inc. (ABBV)
Vinblastine Sulfate	Filana Therapeutics Inc. (FLNA)
Vincristine Sulfate	Filana Therapeutics Inc. (FLNA)
Zanubrutinib	BeOne Medicines Ltd. (ONC)

Compare drugs

aucatzyl vs azacitidine aucatzyl vs belrapzo aucatzyl vs bosutinib

Frequently asked questions

How many drugs are in development for Leukemia?

BioSniper tracks 630 drugs in development for Leukemia across 136 companies.

How many clinical trials target Leukemia?

There are 25 clinical trials targeting Leukemia tracked by BioSniper.

What is the prevalence of Leukemia?

The estimated prevalence of Leukemia is approximately 6.0 per 100,000 population.

Deep-dive into Leukemia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis